ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Global, regional, and national burden of Early-onset Parkinson's disease: A comprehensive analysis and forecast, 1990-2021.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesEarly-onset Parkinson's disease (EOPD), defined as Parkinson's disease with onset between ages 21 and 50 years, profoundly impairs young individuals' productivity and mental health, imposing substantial economic and familial burdens. However, comprehensive global epidemiological data remain limited. This study aimed to assess the worldwide burden, key drivers, and projected trends of EOPD.
methodsUsing Global Burden of Disease Study 2021 data, we examined incidence, prevalence, deaths, disability-adjusted life years (DALYs), and age-standardised rates(ASRs) for EOPD from 1990 to 2021, stratified by sex, age, region, country, and socio-demographic index (SDI). Temporal trends were evaluated with estimated annual percentage changes (EAPC); SDI associations via Spearman's correlation; inequalities via slope index of inequality(SII) and concentration index(CI); drivers via decomposition analysis; and future projections via Bayesian age-period-cohort(BAPC) models with integrated nested Laplace approximation.
resultsFrom 1990 to 2021, the global burden of EOPD increased substantially: in 2021, incident cases reached 81,047 (95% UI: 48,162-122,328), prevalent cases 483,872 (95% UI: 328,862-682,509), deaths 2,246 (95% UI: 1,995-2,496), and DALYs 180,325 (95% UI: 145,990-225,031)-representing 2.9-, 2.5-, 1.7-, and 1.9-fold increases from 1990, respectively. ASIR (EAPC 1.42%, 95% CI: 1.26-1.58) and ASPR (EAPC 1.09%, 95% CI: 1.02-1.16) increased; ASMR declined (EAPC - 0.42%, 95% CI: -0.45 to - 0.39), driven largely by middle- and high-middle-SDI regions; ASDR remained stable. Males exhibited higher burden, particularly for deaths and DALYs. Burden was stable in patients aged ≤ 34 years; absolute numbers peaked in middle-SDI regions, East Asia, and South Asia, with the highest ASRs in middle- and high-middle-SDI regions and Andean Latin America. Socioeconomic inequities persisted, with modest widening for incidence and prevalence. Decomposition attributed rises in morbidity primarily to epidemiological changes and population growth, and rises in mortality and DALYs to population growth and ageing, with marked SDI heterogeneity. Projections to 2036 forecast continued absolute increases, stabilising incidence and prevalence rates, and declining mortality and DALY rates.
conclusionsThe global burden of EOPD continues to rise, accompanied by notable spatial and demographic disparities. Drivers of burden changes vary significantly across regions and are closely associated with the SDI. Targeted policy interventions and resource allocation are required to address these challenges effectively.
Indexed as
Identifiers
41876889What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.